Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CDP-1 (cetuximab biosimilar)
i
Other names:
CDP-1, CDP1, BC001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Guilin SanJin Group
Drug class:
EGFR antagonist
Related drugs:
‹
CKD-702 (6)
SCT200 (4)
CPGJ-602 (3)
rezivertinib (2)
MCLA-158 (2)
BTG-002814 (0)
KL 140 (cetuximab biosimilar) (0)
CKD-702 (6)
SCT200 (4)
CPGJ-602 (3)
rezivertinib (2)
MCLA-158 (2)
BTG-002814 (0)
KL 140 (cetuximab biosimilar) (0)
›
Associations
News
Trials
Filter by
Latest
4ms
Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=32, Completed, Dragonboat Biopharmaceutical Company Limited | Unknown status --> Completed
4 months ago
Trial completion • Metastases
|
BRAF (B-raf proto-oncogene) • RAS (Rat Sarcoma Virus)
|
cisplatin • paclitaxel • CDP-1 (cetuximab biosimilar)
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login